The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $141.96 million versus the consensus estimate of $139.79 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2026 revenue of $630-650 million, versus the consensus of $636.2 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.